These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35063677)

  • 1. Ceftriaxone-associated encephalopathy in a patient with high levels of ceftriaxone in blood and cerebrospinal fluid.
    Nishioka H; Cho Y; Irie K; Kanamori M
    Int J Infect Dis; 2022 Mar; 116():223-225. PubMed ID: 35063677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephalopathy induced by high levels of ceftriaxone in the blood and cerebrospinal fluid.
    Minamii T; Shimizu H; Irie K; Nishioka H
    IDCases; 2022; 29():e01581. PubMed ID: 35938149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.
    Suzuki S; Naito S; Numasawa Y; Asada M; Shoji N; Zeniya M; Takahashi D; Sato H; Iimori S; Nomura N; Sohara E; Okado T; Ishiwata Y; Nagata M; Rai T; Yokota T; Uchida S
    Intern Med; 2019 Jun; 58(12):1775-1779. PubMed ID: 30799339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone-induced acute reversible encephalopathy in a patient treated for a urinary tract infection.
    Roncon-Albuquerque R; Pires I; Martins R; Real R; Sousa G; von Hafe P
    Neth J Med; 2009 Feb; 67(2):72-5. PubMed ID: 19299850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients.
    Onogi C; Osada A; Imai K; Mimura T; Saka Y; Urahama Y; Oishi H; Naruse T
    Hemodial Int; 2022 Jul; 26(3):E27-E30. PubMed ID: 35441472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-induced Neurotoxicity in a Patient after Pancreas-Kidney Transplantation.
    Hagiya H; Miyawaki K; Yamamoto N; Yoshida H; Kitagawa A; Asaoka T; Eguchi H; Akeda Y; Tomono K
    Intern Med; 2017 Nov; 56(22):3103-3107. PubMed ID: 28943562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review.
    Kim KB; Kim SM; Park W; Kim JS; Kwon SK; Kim HY
    J Korean Med Sci; 2012 Sep; 27(9):1120-3. PubMed ID: 22969263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report.
    Yokoyama Y; Hosokawa N; Kudo T; Goda H; Ito K; Suzuki M; Funakoshi R
    J Infect Chemother; 2020 Mar; 26(3):285-288. PubMed ID: 31680037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of ceftriaxone concentration in human cerebrospinal fluid by high-performance liquid chromatography with UV detection.
    Kotani A; Hirai J; Hamada Y; Fujita J; Hakamata H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Aug; 1124():161-164. PubMed ID: 31202181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone-induced fixed drug eruption: first report.
    Ozkaya E; Mirzoyeva L; Jhaish MS
    Am J Clin Dermatol; 2008; 9(5):345-7. PubMed ID: 18717612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone-induced hemolysis.
    Guleria VS; Sharma N; Amitabh S; Nair V
    Indian J Pharmacol; 2013; 45(5):530-1. PubMed ID: 24130395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone-associated acute gallbladder enlargement - an unexpected diagnosis in the child with urinary tract infection.
    Krzemień G; Książczyk T; Szmigielska A; Bombiński P; Roszkowska-Blaim M; Werner B; Brzewski M
    Dev Period Med; 2015; 19(2):182-5. PubMed ID: 26384120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report.
    Jacquot C; Moayeri M; Kim B; Shugarts S; Lynch KL; Leavitt AD
    Transfusion; 2013 Nov; 53(11):2715-21. PubMed ID: 23451879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute interstitial nephritis associated with coadministration of vancomycin and ceftriaxone: case series and review of the literature.
    Plakogiannis R; Nogid A
    Pharmacotherapy; 2007 Oct; 27(10):1456-61. PubMed ID: 17896901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of intravenous ceftriaxone followed by oral cefixime versus ceftriaxone alone in the treatment of severe upper urinary tract infections].
    Regnier B
    Presse Med; 1989 Oct; 18(32):1617-21. PubMed ID: 2530546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of ertapenem versus ceftriaxone in a double-blind study performed in children with complicated urinary tract infection, community-acquired pneumonia or skin and soft-tissue infection.
    Arguedas A; Cespedes J; Botet FA; Blumer J; Yogev R; Gesser R; Wang J; West J; Snyder T; Wimmer W;
    Int J Antimicrob Agents; 2009 Feb; 33(2):163-7. PubMed ID: 18945594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre clinical study on the injection of ceftriaxone/sulbactam compared with cefoperazone/sulbactam in the treatment of respiratory and urinary tract infections.
    Xin X; Jian L; Xia X; Jia B; Huang W; Li C; Wang C; Zhou L; Sun X; Tang X; Huang Y; Zhu Y; Zhang W
    Ann Clin Microbiol Antimicrob; 2013 Dec; 12():38. PubMed ID: 24321187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
    Wells WG; Woods GL; Jiang Q; Gesser RM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study.
    Tomera KM; Burdmann EA; Reyna OG; Jiang Q; Wimmer WM; Woods GL; Gesser RM;
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2895-900. PubMed ID: 12183244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftriaxone-induced Encephalopathy: A Pharmacokinetic Approach.
    Jadot L; Judong A; Canivet JL; Lorenzo-Villalba N; Damas P
    Eur J Case Rep Intern Med; 2021; 8(11):003011. PubMed ID: 34912745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.